Upload Avatar (500 x 500)
姜海
Life Science
中国科学院大学
北京
Language: 英语, 中文
药物靶点
筛选系统
侵袭性淋巴瘤
早期诊断
化疗
疗效预测
基因功能
应用
小鼠模型
肿瘤抑制因子
Areas of Focus
- 药物靶点筛选
- 侵袭性淋巴瘤早期诊断
- 化疗药物疗效预测
- 基因功能与应用
Publications
- DCK confers sensitivity of DCTD-positive cancer cells to oxidized methylcytidines, 姜海, 2022
- Defining relative mutational difficulty to understand cancer formation, Shan, Lin, Yu, Jiao, He, Zhengjin, Chen, Shishuang, Liu, Mingxian, Ding, Hongyu, Xu, Liang, Zhao, Jie, Yang, Ailing, Jiang, Hai, 2020
- SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling, Liang Xu, Peixue Li, Xue Hao, Yi Lu, Mingxian Liu, Wenqian Song, Lin Shan, Jiao Yu, Hongyu Ding, Shishuang Chen, Ailing Yang, Yi Arial Zeng, Lei Zhang, Hai Jiang, 2020
- Systematic Analysis of Drug Vulnerabilities Conferred by Tumor Suppressor Loss, 丁红玉, 赵洁, 张艳丽, 于皎, 刘明贤, 李晓曦, 徐亮, 林明辉, 刘川, 何正金, 陈奭爽, 姜海, 2019
- UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma, 李晓曦, 张艳丽, 郑丽婷, 刘明贤, 陈德桂, 姜海, 2018
- A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk, 王宁, 丁红玉, 刘川, 李晓曦, 魏丽, 于皎, 刘明贤, 应明, 高伟, 姜海, 王亚杰, 2015
- A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency, 刘川, 丁红玉, 李晓曦, Pallasch, Christian P, 洪丽雅, 郭殿武, 陈奭爽, 王迪飞, 王伟, 王亚杰, Hemann, Michael T, 姜海, 2015
